Clinical Trial Update: CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr [NA]

View source ↗

Summary

The document reports a clinical trial evaluating CyberKnife ultra-hypofractionated SBRT for localized prostate cancer, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Prostate Cancer | NA | Status: RECRUITING